Podcasts about adjunctive

We talk with the nicest person in Implementation Science, Byron Powell about how his dream of being a high school social worker and basketball coach was derailed by the irresistible siren song of implementation science, the meaning of interventions and implementation strategies, the utility of mechanism diagramming using approaches like logic models and causal pathway diagrams, and Kevin and I get Byron started on a rant about implementation science. Contact Byron @byron_powell on X Discussed during today's show: Geng, E. H., Nash, D., Phanuphak, N., Green, K., Solomon, S., Grimsrud, A., Sohn, A. H., Mayer, K. H., Bärnighausen, T., & Bekker, L. G. (2022). The question of the question: impactful implementation science to address the HIV epidemic. Journal of the International AIDS Society, 25(4), e25898. https://doi.org/10.1002/jia2.25898 Powell, B.J., Waltz, T.J., Chinman, M.J. et al. A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project. Implementation Sci 10, 21 (2015). https://doi.org/10.1186/s13012-015-0209-1 Pullmann, M. D., Dorsey, S., Duong, M. T., Lyon, A. R., Muse, I., Corbin, C. M., Davis, C. J., Thorp, K., Sweeney, M., Lewis, C. C., & Powell, B. J. (2022). Expect the Unexpected: A Qualitative Study of the Ripple Effects of Children's Mental Health Services Implementation Efforts. Implementation research and practice, 3, 26334895221120797. https://doi.org/10.1177/26334895221120797 Smith, J. D., Li, D. H., Merle, J. L., Keiser, B., Mustanski, B., & Benbow, N. D. (2024). Adjunctive interventions: change methods directed at recipients that support uptake and use of health innovations. Implementation science : IS, 19(1), 10. https://doi.org/10.1186/s13012-024-01345-z

Send us a Text Message.Vasopressin as adjunctive therapy in pulmonary hypertension associated with refractory systemic hypotension in term newborns.Santelices F, Masoli D, Kattan J, Toso A, Luco M.J Perinatol. 2024 Jul 4. doi: 10.1038/s41372-024-02015-0. Online ahead of print.PMID: 38965377 As always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

My very good friend, acupuncturist and expert in eastern holistic medicine, Robert Herbst, shares how acupuncture and holistic medicine helped him to achieve long term sobriety and freedom from the horrors of panic disorder. Robert is the co-owner of the Care Wellness Center in Margate, Florida, where he continues his recovery journey by helping others with substance use disorders, mental health concerns and an array of medical issues.

“I would love for the psychoanalytic world to re-embrace some of these adjunctive treatments that get to non-ordinary states of consciousness in order to enhance psychoanalytic treatment, and that includes psychedelics. The other thing I'd like to see is, I think psychoanalysts are extremely well suited to use psychedelic-assisted therapy in a non-harmful way. I really believe that without an ongoing treatment relationship that these medicines are not going to be quick fixes. There's an article in the Substack blog, Ecstatic Integration, about an Israeli man who had an MDMA treatment for chronic post-traumatic stress disorder and it's a very interesting read, and it really does speak to the crucial aspect of having an ongoing therapy relationship while we use these medicines. I want people who are in the analytic field who are trained right out of the box to provide these containers to be more involved in the psychedelic field. For the psychedelic field I think sometimes I wish they would be a little more humble, a little less zealous about the efficacy, and a little more concerned about what could happen that's harmful. I also think the psychedelic field, for some reason, has not embraced psychoanalysis as a major tool to enhance the medicine."    Episode Description: Charis begins by discussing her inspiration, attributed to Maimonides, for always seeking new understandings to enhance her care of patients. We also begin with a caution - any time we introduce a frame change in clinical work, we must carefully attend to our countertransference to determine the factors that are contributing to our actions. That said, we should be careful to not use our carefulness to rationalize inhibitions to thinking and acting creatively. Charis describes her thinking underlying her decision to introduce ketamine with a particular patient as well as the process of the ongoing psychotherapy. We discuss the practical aspects of this procedure, the risks, the changes in the patient, and the importance of an ongoing psychotherapy to serve as a productive holding and processing space for this work. She concludes with her recommendation to the analytic world to be more open to such adjunctive approaches to therapy and to the psychedelic world to be more modest in their assumptions of its healing ability.   Linked Webinar and Article:  /g/Communications/Ees4tjM0U1lEtzEkVrUmDjgBmH9Vd6wgap_-Z-7BJVXNDw?e=h8Afay&referrer=Outlook.Win32&referrerScenario=email-linkwithembed">https://ipaworld.sharepoint.com//g/Communications/Ees4tjM0U1lEtzEkVrUmDjgBmH9Vd6wgap_-Z-7BJVXNDw?e=h8Afay&referrer=Outlook.Win32&referrerScenario=email-linkwithembed   https://www.ecstaticintegration.org/p/successfully-treating-c-ptsd-with?utm…     Our Guest: Dr. Cladouhos is a child, adolescent, and adult psychiatrist and psychoanalyst practicing in Boston, Massachusetts. She is on the faculty at the Tufts University School of Medicine and in the Boston Psychoanalytic Institute's adult and child analytic training programs.  She is the course director of an experiential elective for first-year medical students at Tufts called The Healer's Art: Rekindling the Heart and Soul of Medicine and established a pilot retreat program (First Aid for Physicians) through Tufts Medical Center to address physician burnout. She is trained in EMDR and Deep Brain Reorienting, has completed the first phase of MDMA training through MAPS, and has a certificate in Ketamine Assisted Psychotherapy from the Fluence Center for Psychedelic Training in New York. She is a member of the International Society for the Treatment of Trauma and Dissociation's Special Interest Group on psychoanalytic contributions to the treatment of trauma and dissociation.     Recommended Readings:    Jeffrey Guss (2022) A Psychoanalytic Perspective on Psychedelic Experience, Psychoanalytic Dialogues, 32:5, 452-468, DOI: 10.1080/10481885.2022.2106140    Fischman, Lawrence G. Knowing and being known: Psychedelic-assisted psychotherapy and the sense of authenticity. 09/20/22. Frontiers in Psychiatry. pp.1-36    Lawrence G. Fischman (2019) Seeing without self: Discovering new meaning with psychedelic-assisted psychotherapy, Neuropsychoanalysis, 21:2, 53-78, DOI: 10.1080/15294145.2019.1689528     Dahlberg, Charles Clay. LSD Facilitation of Psychoanalytic Treatment: A Case Study in Depth    Aaron D. Cherniak, Joel Gruneau Brulin, Mario Mikulincer, Sebastian Östlind, Robin Carhart-Harris & Pehr Granqvist (2023) Psychedelic Science of Spirituality and Religion: An Attachment-Informed Agenda Proposal, The International Journal for the Psychology of Religion, 33:4, 259-276, DOI: 10.1080/10508619.2022.2148061   Orbach, S. There Is No Such Thing As A Body. John Bowlby Memorial Lecture: British Journal of Psychotherapy. 20 (1) 3-15 2003   Orbach, S. Body Part 2: Psychoanalysis' Discomfort with Touch. British Journal of Psychotherapy. 20 (1) 17-26.2003.   Essentials of informed consent:   Power Trip: Cover Story New York Magazine. Lily K Ross and David Nickels 

It's never too early to get healthier AND happier! I sit down with Integrative Pediatrician and author of the new book, “Healthy Kids, Happy Kids” Dr. Elisa Song to discuss why gut health may be the key to happier kids. We also explore how parents can help gamify kids' habits in a fun way to improve their lifestyle! You don't want to miss this one - watch now!

Contributor: Aaron Lessen MD Educational Pearls: Opioid overdoses that are reversed with naloxone (Narcan), a mu-opioid antagonist, can precipitate acute withdrawal in some patients Treatment of opioid use disorder with buprenorphine can also precipitate withdrawal Opioid withdrawal symptoms include nausea, vomiting, diarrhea, and agitation Buprenorphine works as a partial agonist at mu-opioid receptors, which may alleviate withdrawal symptoms The preferred dose of buprenorphine is 16 mg Treatment of buprenorphine-induced opioid withdrawal is additional buprenorphine Adjunctive treatments may be used for other opioid withdrawal symptoms Nausea with ondansetron Diarrhea with loperamide Agitation with hydroxyzine References 1. Quattlebaum THN, Kiyokawa M, Murata KA. A case of buprenorphine-precipitated withdrawal managed with high-dose buprenorphine. Fam Pract. 2022;39(2):292-294. doi:10.1093/fampra/cmab073 2. Spadaro A, Long B, Koyfman A, Perrone J. Buprenorphine precipitated opioid withdrawal: Prevention and management in the ED setting. Am J Emerg Med. 2022;58:22-26. doi:10.1016/j.ajem.2022.05.013 Summarized by Jorge Chalit, OMSII | Edited by Meg Joyce & Jorge Chalit  

Recent research highlights that probiotics can make a significant impact on a wide range of conditions like immunity, stress, allergies, and even lactose intolerance.  Tune in to hear the latest updates and stay in step with the science.   Read & Watch Next What is Leaky Gut? https://drruscio.com/what-is-leaky-gut/  How to Use Probiotics for Bloating & Constipation Relief: https://drruscio.com/probiotics-for-bloating/   How Long Does it Take for Probiotics to Work? https://drruscio.com/how-long-does-it-take-for-probiotics-to-work/  7 Surprising Things That are Stressing Your Nervous System: https://drruscio.com/things-stressing-your-nervous-system/  The Latest Research Update Episodes: https://drruscio.com/research-updates/   Why You Have Food Intolerances & How to Improve Them: https://www.youtube.com/watch?v=y-LNHKlk5Oc&t=14s    Timestamps 00:00 Intro  00:56 Benefits for white blood cells 04:11 Benefits for diarrhea & sickness duration 08:13 Benefits for the stress response  13:21 Benefits for food allergies  19:22 Research update wrap-up   Featured Studies  Effect of synbiotic supplementation on immune parameters and gut microbiota in healthy adults: a double-blind randomized controlled trial: https://pubmed.ncbi.nlm.nih.gov/37614109/ Adjunctive efficacy of Lactis XLTG11 for Acute diarrhea in children: A randomized, blinded, placebo-controlled study: https://pubmed.ncbi.nlm.nih.gov/37172455/ The effect of oral probiotics on CD4 count in patients with HIV infection undergoing treatment with ART who have had an immunological failure: https://pubmed.ncbi.nlm.nih.gov/37382253/ Effects of Heat-Killed Lacticaseibacillus paracasei MCC1849 on the Maintenance of Physical Condition in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study: https://pubmed.ncbi.nlm.nih.gov/37571384/ Potential probiotics for regulation of the gut-lung axis to prevent or alleviate influenza in vulnerable populations: https://pubmed.ncbi.nlm.nih.gov/36970463/ Bifidobacterium longum subsp. longum Reduces Perceived Psychological Stress in Healthy Adults: An Exploratory Clinical Trial: https://pubmed.ncbi.nlm.nih.gov/37513541/ Intake of Lactiplantibacillus plantarum HEAL9 Improves Cognition in Moderately Stressed Subjects: A Randomized Controlled Study: https://pubmed.ncbi.nlm.nih.gov/37571403/ Exaggerated amygdala response to threat and association with immune hyperactivity in depression: https://pubmed.ncbi.nlm.nih.gov/35636614/ Probiotics fortify intestinal barrier function: a systematic review and meta-analysis of randomized trials: https://pubmed.ncbi.nlm.nih.gov/37168869/ The role of probiotic supplementation in inflammatory biomarkers in adults: an umbrella meta-analysis of randomized controlled trials: https://pubmed.ncbi.nlm.nih.gov/37698776/ Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome: https://pubmed.ncbi.nlm.nih.gov/28483500/ Lacticaseibacillus rhamnosus HA-114 improves eating behaviors and mood-related factors in adults with overweight during weight loss: a randomized controlled trial: https://pubmed.ncbi.nlm.nih.gov/35714163/ The Effectiveness of Probiotics in Treating Food and Cow's Milk Allergies among Pediatric Age Group: A Meta-analysis of Randomized Controlled Trials: https://pubmed.ncbi.nlm.nih.gov/37496406/ Effects of probiotics administration on lactose intolerance in adulthood: A meta-analysis: https://pubmed.ncbi.nlm.nih.gov/37225575/   Get the Latest Updates Facebook - https://www.facebook.com/DrRusciodc Instagram - https://www.instagram.com/drrusciodc/ Pinterest - https://www.pinterest.com/drmichaelrusciodc  DISCLAIMER: The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider before starting any new treatment or discontinuing an existing treatment. Music featured in this video: "Modern Technology" by Andrew G, https://audiojungle.net/user/andrew_g  *Full transcript available on YouTube by clicking the “Show transcript” button on the bottom right of the video.

Direct Peritoneal Resuscitation!  We're not just dumping fluids into the open abdomen.  What is DPR?  Why do it?  Who should get it?  Does it work? Come try and stay awake for some basic science talk before then learning all about why you should consider adopting DPR into your Trauma/EGS practice? Join Drs. Cobler-Lichter, Kwon, Meizoso, Urréchaga, and Rattan as they guide you through all this and more!  Hosts: Michael Cobler-Lichter, MD, PGY2: University of Miami/Jackson Memorial Hospital/Ryder Trauma Center @mdcobler (twitter) Eva Urrechaga, MD, PGY6/R4: University of Miami/Jackson Memorial Hospital/Ryder Trauma Center @urrechisme (twitter) Eugenia Kwon, MD, Trauma/Surgical Critical Care Fellow: University of Miami/Jackson Memorial Hospital/Ryder Trauma Center Jonathan Meizoso, MD, MSPH Assistant Professor of Surgery, 3 years in practice University of Miami/Jackson Memorial Hospital/Ryder Trauma Center @jpmeizoso (twitter) Rishi Rattan, MD, Attending Surgeon in Trauma/Critical Care, 7 years in practice Legacy Emanuel Medical Center @DrRishiRattan (twitter) Learning Objectives: - State the proposed benefits of DPR - Identify who can benefit from DPR - Demonstrate the proper way to set up a DPR circuit - Discuss the proposed basic science mechanism for DPR's efficacy Quick Hits: 1.      Consider DPR in all your open abdomens in EGS/Trauma.  You never know when you're going to be able to close some of these patients. 2.     The principal of DPR is to allow the fluid to dwell in the abdomen as long as possible.  Keep the catheter deep and don't put holes in your dressing. 3.     DPR is ideal for patients with packing, who are in discontinuity, and for fresh anastomoses.  These will only benefit from DPR, not be harmed by it.  4.     Make sure these patients are receiving hourly I/Os.  Nursing by-in is huge for this procedure. 5.     DPR is associated with higher rates of fascial closure, reduces inflammation, and improves blood flow to the abdomen. References Ribeiro-Junior MAF, Cássia Tiemi Kawase Costa, de Souza Augusto S, et al. The role of direct peritoneal resuscitation in the treatment of hemorrhagic shock after trauma and in emergency acute care surgery: a systematic review. Eur J Trauma Emerg Surg. Published online November 13, 2021. doi:10.1007/s00068-021-01821-x Smith JW, Garrison RN, Matheson PJ, Franklin GA, Harbrecht BG, Richardson JD. Direct Peritoneal Resuscitation Accelerates Primary Abdominal Wall Closure after Damage Control Surgery. J Am Coll Surg. 2010;210(5):658-667. doi:10.1016/j.jamcollsurg.2010.01.014 Smith JW, Neal Garrison R, Matheson PJ, et al. Adjunctive treatment of abdominal catastrophes and sepsis with direct peritoneal resuscitation: indications for use in acute care surgery. J Trauma Acute Care Surg. 2014;77(3):393-398; discussion 398-399. doi:10.1097/TA.0000000000000393 Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episode here: https://behindtheknife.org/listen/

Caris Precision Oncology Alliance™ Chairman, Dr. Chadi Nabhan, sits down with Dr. Charu Aggarwal, the Leslye M. Heisler Associate Professor for Lung Cancer Excellence at UPENN, and Dr. Balazs Halmos, Director, Thoracic Oncology at Montefiore. Together they discuss adjuvant and neoadjuvant therapy for resected non-small cell lung cancer (NSCLC). Topics discussed will include current treatment options, how treatment decision are made, and when treatment should be given. For more information, please visit: www.CarisLifeSciences.com/POA-Intro/

Discover the potential of a groundbreaking wave known as Epsilon Waves, which holds the promise of positively impacting conditions such as ADHD and other related challenges. Epsilon Waves are a type of brainwave that operates at a frequency range of 0.5 to 0.1 Hz, representing an ultra-low frequency range that is still being extensively researched. Preliminary studies suggest that Epsilon Waves have the potential to influence brain activity and promote a state of deep relaxation and focus. This unique brainwave frequency is believed to facilitate the synchronization of neural networks and enhance cognitive functions such as attention and concentration. For individuals with ADHD, Epsilon Waves may offer a novel approach to manage symptoms and improve focus. By stimulating these specific brainwave patterns, it is thought that Epsilon Waves can help regulate neural activity and promote a calmer, more centered state of mind. However, further research is still needed to fully understand the impact and benefits of Epsilon Waves on various conditions. It is important to note that the study and application of Epsilon Waves are still in the early stages, and their potential benefits should be explored under the guidance of qualified professionals. As research progresses, scientists and healthcare practitioners are striving to uncover the full extent of Epsilon Waves' therapeutic possibilities. If you or a loved one are interested in exploring Epsilon Waves as a potential adjunctive therapy, it is crucial to consult with a healthcare professional experienced in neurology or cognitive neuroscience. They can provide the necessary guidance and resources to ensure a safe and informed approach. As research continues, the understanding of Epsilon Waves and their potential impact on conditions like ADHD may evolve, providing new possibilities for individuals seeking alternative and complementary approaches to managing their health and well-being. Epsilon Waves, ADHD, Brainwave frequency, Deep relaxation, Focus, Neural networks, Cognitive functions, Attention, Concentration, Synchronization, Brain activity, State of mind, Symptoms, Neural activity, Calm, Centered, Research, Benefits, Therapeutic possibilities, Early stages, Qualified professionals, Adjunctive therapy, Neurology, Cognitive neuroscience, Healthcare professional, Safe, Informed approach, Alternative approaches, Complementary approaches, Health, Well-being. Support our mission of spreading relaxation and wellness by rating and reviewing our podcast on your preferred platform. Your feedback helps us improve and enables others to discover the benefits of our soothing sounds. Enhance your listening experience by subscribing to our ad-free version, immersing yourself in uninterrupted tranquility.  Clicking Here  Join our community of relaxation seekers and embark on a journey of self-discovery. Subscribe, rate, and review Meditation Sounds today and unlock a world of serenity and rejuvenation.  Email List Support this podcast  https://www.meditationsoundspodcast.com Say goodbye to stubborn belly fat with our revolutionary product! Our formula is designed to target and dissolve unwanted fat, leaving you with a slimmer, more toned midsection. Try it now and experience the results for yourself. #dissolvebellyfat #slimandtoned http://bit.ly/3jV1Ip1 Learn more about your ad choices. Visit megaphone.fm/adchoices

If you're trying to boost your immune system, Thrive IV ((508) 848-8089) in Dartmouth offers specially tailored IV therapy as an adjunctive treatment that can increase the effectiveness of your primary care. Go to https://www.thriveiv.net/ Thrive IV 49 State Rd Nauset Building #102, Dartmouth, MA 02747, United States Website http://www.ThriveIV.net Phone +1-508-848-8089 Email ThriveIVKetamine@gmail.com

#neurofeedbackpodcast #neurofeedback #eeg #epilepsy #mentaltraining #casereport Jay Gunkelman is the man who has read over 500,000 Brain Scans and he comes on the NeuroNoodle Neurofeedback and Mental Health Podcast to talk about ISNR Case Report NeuroRegulation Intractable Epilepsy Controlled by Neurofeedback and Adjunctive Treatments  @isnr2797  https://www.neuroregulation.org/issue/view/1690/257http://www.isnr.org21| www.neuroregulation.orgVol. 10(1):21–302023doi:10.15540/nr.10.1.21 Key Moments: 0:001:37 Show Start 2:29 Dr Rusty Turner 2:50 Susan Wilson 3:40 Linda Walker 5:45 Start of Screen Share by Jay Gunkelman 7:58 Spectra Readings 19:22 Clean EEG after training 23:30 Remove Part of Brain is alternative 24:20 Neurofeedback is Non invasive option --- Send in a voice message: https://podcasters.spotify.com/pod/show/neuronoodle/message Support this podcast: https://podcasters.spotify.com/pod/show/neuronoodle/support

CME credits: 1.75 Valid until: 31-03-2024 Claim your CME credit at https://reachmd.com/programs/cme/thinking-out-of-the-box-monotherapies-versus-adjunctive-therapies-in-bipolar-i-and-ii-depression/15296/ Given the nature of symptom presentation of bipolar depression, patients can go undiagnosed for months, if not years. Moreover, these patients are at the risk of being misdiagnosed as having unipolar depression rather than bipolar depression, causing them to be at greater risk for being mismanaged. Effective management of patients with bipolar 1 and 2 depression is vital to enhance their quality of life and reduce functional disability. Health care providers (HCPs) need to be aware of the shortcomings of traditional monotherapy and adjunctive therapies; considering the ramifications associated with their side effects and efficacy, they have both adherence challenges and significant relapse rates. Additionally, HCPs must stay abreast of the pharmacological profiles of new and emerging agents. This program discusses the timely diagnosis and effective management of bipolar 1 and 2 depression. Furthermore, clinicians will become familiar with algorithms and guidelines for effectively diagnosing and managing patients with bipolar depression. Through the timely diagnosis and effective management of patients with bipolar 1 and 2 depression, these patients spend less time unwell and their overall quality of life and functional outcomes are positively impacted.

In episode 2 of 9, host Edward di Girolamo speaks with world renowned HBOT expert, Dr. Paul G. Harch on thermal burns, FDA approvals, the misguidance of physicians towards HBOT and insurance coverage. di Girolamo immediately stresses that he wants to better understand what the roadblock is, why are more burn victims not using Hyperbaric Oxygen Therapy? Dr. Harch explains that it's simple, they don't know about it.di Girolamo tells a story about his journey to educate a doctor in Galvenston, TX who oversees a handful of hospitals known to treat youth burn victims. He spent time chatting with the doctor via phone, and educating the physician that the FDA has now cleared hyperbaric oxygen as a treatment for thermal burns. During the conversation, di Girolamo outlined the benefits of HBOT as a better and more painless treatment option for these children. The doctor stated that he was excited and interested; and welcomed di Girolamo to send him a copy of UHMS's referenced research on thermal burns that ultimately led to the FDA clearance. The research by Dr. Cianci, “Adjunctive hyperbaric oxygen therapy in the treatment of thermal burns” was overnighted and received/signed for. After that, the Galveston, TX doctor refused to take di Girolamo's calls. di Girolamo later discovered that this particular doctor was also the head of the plastic surgery unit. He believes that the doctor's hesitation to embrace Hyperbaric Oxygen Therapy, a potentially safer and painless recovery method for youth burn victims, had everything to do with the reduction of plastic surgeries the hospital would have seen.Dr. Harch stresses that the timing of this conversation about thermal burns is impeccable; it was only a few months ago that he had given a lecture on this. He reviewed all of the literature on hyperbaric oxygen in burns and part of the problem was the randomized trials. Every doctor in medicine wants randomized trials. There's some real positive information that exists and there's neutral information – it's mixed. But, yet there are many articles out there that support it, and the animal literature is overwhelming for burns. Harch explains that one of the key things to using HBOT to treat thermal burns is that the therapy is most effective when it's done almost immediately to treat the inflammatory part of the burn injury; the reperfusion injury. If you get to it early enough, HBOT can deliver a dramatic improvement. However, even if it's delayed hyperbaric oxygen therapy still has many positive qualities of healing, because it reduces swelling in every traumatic and injurious condition. There is literature and science to support this in just about every organ system where it's been applied.Harch continues to educate on using HBOT for thermal burns and stresses that if used immediately after an acute burn, it can reduce swelling. This reduction in swelling will prevent the progression from second degree, deep second degree, to third degree. It's when it gets to third degree that burn patients have to cut off the skin and are in need of a skin graft, which is very painful plastic surgery process with horrendous scarring. Hyperbaric oxygen therapy has the evidence to support this, and the ability to reduce the swelling and prevent that deep second to third degree conversion. Harch tells us that if a burn patient can do that, then the number of debridements, surgeries, and skin graftings is reduced.But, then the question remains….. who is going to pay for the Hyperbaric

Dr. Gary S. Sachs (Harvard Medical School) joins us for the for the March episode of AJP Audio, discussing the results from a phase 3 study looking at the use of atypical antipsychotic cariprazine as an adjunctive treatment for major depression in conjunction with antidepressants.  Afterwards, we'll be joined once again by AJP Editor-in-Chief Dr. Ned Kalin to discuss the rest of the March issue. Transcript Sachs interview [00:47] Why is treating major depressive disorder in patients proven to be such a challenge for clinicians? [01:54] Why cariprazine in conjunction with antidepressants? [02:37] Atypical antipsychotics and antidepressants [03:22] Atypical antipsychotics and side effects [05:23] Limitations [07:09] Clinical implications for the treatment of major depressive disorder [08:29] What's next for your research? [09:15] Kalin interview [10:09] Sachs et al. [10:25] Hasseris et al. [12:35] Visontay et al. [15:15] Dunlop et al. [17:10] Elbau et al. [19:56] Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Stitcher, Spotify, or wherever you listen to it. Subscribe to the podcast here. Listen to other podcasts produced by the American Psychiatric Association. Browse articles online. How authors may submit their work. Follow the journals of APA Publishing on Twitter. E-mail us at ajp@psych.org

https://psychiatry.dev/wp-content/uploads/speaker/post-11939.mp3?cb=1677095420.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Efficacy and safety of adjunctive therapy with fingolimod in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial – Monire Karbalaee etFull EntryEfficacy and safety of adjunctive therapy with fingolimod in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial –

In this episode, Rachel Wall, RDH, BS joins me at the Voices of Dentistry conference and we talk about how to better support hygienists through learning about adjunctive therapy and what that can do for our patients. She also has some sage advice for those out there that might feel a little down or burnt out and that is to surround yourself by hygienists who love hygiene! Rachel advocates for you to speak your mind, stand up and be a leader in your practice and if you need pointers, send her a message by heading over to http://www.inspiredhygiene.com   www.VoicesofDentistry.com  

In this episode, Rachel Wall, RDH, BS joins me at the Voices of Dentistry conference and we talk about how to better support hygienists through learning about adjunctive therapy and what that can do for our patients. She also has some sage advice for those out there that might feel a little down or burnt out and that is to surround yourself by hygienists who love hygiene! Rachel advocates for you to speak your mind, stand up and be a leader in your practice and if you need pointers, send her a message by heading over to http://www.inspiredhygiene.com   www.VoicesofDentistry.com  

About our Guest:Dr. Yehya is a graduate of the University of California at Berkeley and the University of California at Los Angeles School of Medicine. After completing pediatrics training at Children's Hospital of Los Angeles, he completed his pediatric critical care fellowship at Children's Hospital of Philadelphia (CHOP), and joined the faculty after graduation in 2011. He is currently an Assistant Professor of Anesthesiology and Critical Care and Pediatrics at the Perelman School of Medicine at the University of Pennsylvania and an attending physician in the pediatric intensive care unit at CHOP.Dr. Yehya's research interests encompass all aspects of pediatric respiratory failure, with a particular emphasis on pediatric acute respiratory syndrome (ARDS) and mechanical ventilation. ARDS consists of sudden, severe flooding of the lungs in response to an inflammatory insult causing difficulty breathing, frequently requiring mechanical ventilation. Sepsis is a leading cause of ARDS in children. His long-term goal is better characterization of ARDS in children and to test therapies designed to improve outcomes. His NIH-funded work is assessing the utility of specific plasma biomarkers in pediatric ARDS, with subsequent proteomic characterization and testing in pre-clinical models. Dr. Yehya has several active studies involving biomarkers, clinical epidemiology, and pathophysiological mechanisms in the field of pediatric ARDS, and is involved in several multicenter and multinational collaborations.Objectives:After listening to this episode, learners should be able to:Describe the rationale supporting and “ideal” patient that may benefit from various adjunctive therapies for PARDS:Corticosteroids Neuromuscular blockadeProne positioning Inhaled nitric oxide SurfactantAcknowledgement:Thank you to Dr. Nick Bartel for his help in creating learning objectives for this series.How to support PedsCrit:Please rate and review on Spotify and Apple Podcasts!Donations are appreciated @PedsCrit on Venmo , you can also support us by becoming a patron on Patreon. 100% of funds go to supporting the show.Thank you for listening to this episode of PedsCrit. Please remember that all content during this episode is intended for educational and entertainment purposes only. It should not be used as medical advice. The views expressed during this episode by hosts and our guests are their own and do not reflect the official position of their institutions. If you have any comments, suggestions, or feedback-you can email us at pedscritpodcast@gmail.com. Check out http://www.pedscrit.com for detailed show notes. And visit @critpeds on twitter and @pedscrit on instagram for real time show updates.Selected references:PMID: 10793162PMID: 25693014.PMID: 15269312PMID: 30361119PMID: 17426195PMID: 31112383PMID: 25647235PMID: 19001507PMID: 32043986.PMID: 15671432.Support the show

https://psychiatry.dev/wp-content/uploads/speaker/post-10306.mp3?cb=1665595506.mp3 Playback speed: 0.8x 1x 1.3x 1.6x 2x Download: Efficacy of Adjunctive D-Cycloserine to Intermittent Theta-Burst Stimulation for Major Depressive Disorder: A Randomized Clinical Trial – Jaeden Cole et al. JournalFull EntryEfficacy of Adjunctive D-Cycloserine to Intermittent Theta-Burst Stimulation for Major Depressive Disorder: A Randomized Clinical Trial –

Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2022.09.13.507749v1?rss=1 Authors: Velazquez Sanchez, C., Muresan, L., Belin, D. Abstract: Some compulsive disorders have been considered to stem from the loss of control over coping strategies, such as displacement. However, the cellular mechanisms involved in the acquisition of coping behaviors and their ensuing compulsive manifestation in vulnerable individuals have not been elucidated. Considering the role of the locus coeruleus (LC) noradrenaline dependent system in stress and related excessive behaviors, we hypothesised that neuroplastic changes in the LC may be involved in the acquisition of an adjunctive polydipsic water drinking, a prototypical displacement behavior, and the subsequent development of compulsion in vulnerable individuals. Thus, male Sprague Dawley rats were characterised for their tendency, or not, to develop compulsive polydipsic drinking in a schedule-induced polydipsia (SIP) procedure before their fresh brains were harvested. A new quantification tool for RNAscope assays revealed that the development of compulsive adjunctive behavior was associated with a low mRNA copy number of the plasticity marker Arc in the LC which appeared to be driven by specific adaptations in an ensemble of tyrosine hydroxylase (TH)+, zif268- neurons. This ensemble was specifically engaged by the expression of compulsive adjunctive behavior, not by stress, because its functional recruitment was not observed in individuals that no longer had access to the water bottle before sacrifice while it consistently correlated with the levels of polydipsic water drinking only when it had become compulsive. Together these findings suggest that downregulation of Arc mRNA levels in a population of a TH+zif268- LC neurons represents a signature of the tendency to develop compulsive coping behaviors. Copy rights belong to original authors. Visit the link for more info Podcast created by PaperPlayer

In this episode: the adjunct experience teaching at multiple universities, record amount of teaching -- 14 courses in one semester, plus a full-time job as a swim coach, evil policies universities have toward adjuncts and overload teaching, healthcare benefits, the benefit and cost of flexibility, how to value your adjunct colleagues

About our Guest:Dr. Yehya is a graduate of the University of California at Berkeley and the University of California at Los Angeles School of Medicine. After completing pediatrics training at Children's Hospital of Los Angeles, he completed his pediatric critical care fellowship at Children's Hospital of Philadelphia (CHOP), and joined the faculty after graduation in 2011. He is currently an Assistant Professor of Anesthesiology and Critical Care and Pediatrics at the Perelman School of Medicine at the University of Pennsylvania and an attending physician in the pediatric intensive care unit at CHOP.Dr. Yehya's research interests encompass all aspects of pediatric respiratory failure, with a particular emphasis on pediatric acute respiratory syndrome (ARDS) and mechanical ventilation. ARDS consists of sudden, severe flooding of the lungs in response to an inflammatory insult causing difficulty breathing, frequently requiring mechanical ventilation. Sepsis is a leading cause of ARDS in children. His long-term goal is better characterization of ARDS in children and to test therapies designed to improve outcomes. His NIH-funded work is assessing the utility of specific plasma biomarkers in pediatric ARDS, with subsequent proteomic characterization and testing in pre-clinical models. Dr. Yehya has several active studies involving biomarkers, clinical epidemiology, and pathophysiological mechanisms in the field of pediatric ARDS, and is involved in several multicenter and multinational collaborations.How to support PedsCrit:Please rate and review on Spotify or Apple Podcasts!Donations are appreciated @PedsCrit on Venmo , you can also support us by becoming a patron on Patreon. 100% of funds go to supporting the show.Objectives for this series:By the end of listening to this three-part series, learners should be able to:Recall the diagnostic criteria for pediatric acute respiratory distress syndrome (PARDS). Recall many of different direct and indirect causes of PARDS.Recall the methods used to stratify the severity of PARDS.Recognize the limitations of P/F ratios and the clinical utility of instead using oxygenation index (OI).Describe the rationale and limitations of adjunctive therapies for moderate to severe PARDS.CitationsPediatric Acute Lung Injury Consensus Conference Group. Pediatric acute respiratory distress syndrome: consensus recommendations from the Pediatric Acute Lung Injury Consensus Conference. Pediatr Crit Care Med. 2015;16(5):428-439. doi:10.1097/PCC.0000000000000350 Acute Respiratory Distress syndrome Incidence and Epidemiology (PARDIE) Investigators, & Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network (2019). Paediatric acute respiratory distress syndrome incidence and epidemiology (PARDIE): an international, observational study. The Lancet. Respiratory medicine, 7(2), 115–128. https://doi.org/10.1016/S2213-2600(18)30344-8Thank you for listening to this episode of PedsCrit. Please remember that all content during this episode is intended for educational and entertainment purposes only. It should not be used as medical advice. The views expressed during this episode by hosts and our guests are their own and do not reflect the official position of their institutions. If you have any comments, suggestions, or feedback-you can email us at pedscritpodcast@gmail.com. Check out http://www.pedscrit.com for detailed show notes. And visit @critpeds on twitter and @pedscrit on instagram for real time show updatesSupport the show

Session ‘Update on Adjunctive Sepsis and COVID-19 Therapies' from the 2022 WSC Spotlight. Featuring Evangelos J. Giamarellos-Bourboulis, Alexander Vlaar, Luregn Schlapbach, Sarah Sasson, and Luis Antonio Gorordo Del Sol as your moderator.

Dr. Scott Sherr is the director of Integrative Hyperbaric Medicine and Health Optimization at Hyperbaric Medical Solutions. In this role, he facilitates protocol development, patient engagement, and outreach efforts.   Dr. Scott is also an independent provider of Integrative HBOT who runs a worldwide education, consulting, and advocacy telemedicine practice. He is of the few HBOT medical professionals in the country who develops personalized treatment plans for patients, which include: Cutting edge and dynamic HBOT protocols Health Optimization Medicine (HOMe) testing and balancing Adjunctive technologies Allied practitioner referral Description: In this cutting-edge episode, Kristin shares time with Dr. Scott Sherr talking about hyperbaric oxygen therapy, nootropics like blue cannatine and methalane blue, family matters, and ways we can choose the right functional medicine doctor and tools to optimize our health faster than ever before! Dr. Scott Sherr is the director of Integrative Hyperbaric Medicine and Heath Optimization. HBOT is a natural therapy to treat a wide range of disorders and dis-ease. Research suggests HBOT positively affects patients with a wide range of conditions. Highlights: (06:30) Dr. Sherr's Origin Story: His journey and how he started in the medical school (11:20) How Dr. Sherr learned about hyperbaric therapy and did hyperbaric practice (15:51)  What is a Hyperbaric Medicine (18:44) What happens inside the chamber of hyperbaric oxygen therapy  (19:36) Auto-transfusion: What it does to your body  (22:08) Protocols of Hyperbaric Oxygen Therapy (27:30) Conventional Uses of  Hyperbaric Therapy (29:09) The Limitations of Hyperbaric Therapy and why it is not suitable for long term treatments (33:53) Importance of having a coach in biohacking (41:18) Importance of having a healthy gut (46:08) What does a hyperbaric chamber look like and what does it feel to be inside it (50:05) What are the two types of hyperbaric therapy (53:08) When to consider Hyperbaric therapy  (1:04:35) Maximizing time inside the chamber: Why it Matters (1:31:22)   What advice would Dr. Sherr give on his 10-year old self in achieving a higher level of health and happiness Links:  Twitter: https://twitter.com/drsherr?lang=en LinkedIn: https://www.linkedin.com/in/drsherr/

Beta-glucans have the potential to serve as an adjunctive for a range of chronic, inflammatory diseases, alongside its recently documented benefits for COVID-19 patients, a R&D chief has revealed.

2021 Surviving Sepsis Campaign Guideline Updates Special Guests: Carolyn Bell PharmD, BCCCP and Brittany Bissell, PharmD, PhD, BCCCP, FCCM   Reference List: https://pharmacytodose.files.wordpress.com/2022/02/2021-sepsis-guideline-updates-references.pdf   05:00 – General thoughts and historical perspective; 12:10 – qSOFA; 14:44 – Author diversity; 19:10 – IV fluids; 27:15 – Vasopressors; 33:12 – Antibiotics (and antifungals); 46:10 – Adjunctive treatments; 57:40 – Hopes for future guidelines; 61:35 – Gender inequity and sexual harassment in pharmacy   PharmacyToDose.Com @PharmacyToDose on Twitter PharmacyToDose@Gmail.com

La nivel global, anterior pandemiei actuale se considera că în viitorii 20 de ani sănătatea mintală fragilă va fi de departe cea mai mare sursă de dizabilitate; însă contextul pandemic din ultimii ani a accelerat dezvoltarea problemelor de sănătate mintală și emoțională; un studiu* publicat în jurnalul Lancet, de exemplu, a estimat că doar în anul 2020 incidenta depresiei a crescut, la nivel global, cu 28% și cea a anxietății cu 26%, cu o creștere, in Europa, mai mare față de această medie globală, unde se estimează ca ambele provocări emoționale au crescut cu 30% față de anii anteriori pandemiei. Știința abundă în modele și studii care argumentează faptul că dezvoltarea depresiei depinde de inter-dependența a diverși factori și mecanisme, de la vulnerabilități personale (genetice, biologice, emoționale) până la lipsa suportului social și al comunităților care dezvoltă sentimentele de apartenență. Însă, tot studiile arată că din anii 1990 încoace nu s-au înregistrat progrese majore în tratamentul depresiei, probabil pentru că încă sănătatea emoțională și mintală este abordată trunchiat, prin focus exclusiv pe sănătatea creierului fără să integreze și alte aspecte. Descoperiri științifice recente însă deschid noi perspective care explorează relația dintre corp și claritatea mintală și emoțională. Rezultate din domeniul psihoneuroimunologiei arată faptul că sistemul imunitar afectează modul în care o persoană răspunde în fața stresului, ceea ce va contribui la vulnerabilitatea sănătății emoționale. De exemplu studiile arată că există o relație complicată între inflamația din corp și depresie, și arată că aproape o treime dintre persoanele cu depresie au constant niveluri crescute ale inflamației in corp. Sau spus foarte simplu, claritatea gândurilor depinde de sănătatea corpului, și invers, sănătatea corpului depinde de claritatea gândurilor. Subiectele discutate în acest episod Mind Education Podcast cu Claudia Buneci, health coach: rolul neuroinflamației în sănătatea creierului și calitatea vieții emoționale și mintale ce sunt mitocondriile și de ce disfuncționalitățile mitocondriilor favorizează dezvoltarea problemelor de sănătate mintală rolul expunerii la toxine asupra calității vieții de ce respectarea ritmului circadian contribuie la sănătatea fizică și emoțională recomandări practice Studii incluse: *Santomauro, D. F. et al. (2021). Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. The Lancet. 398(10312);1700-1712, November 06, 2021. DOI: https://doi.org/10.1016/S0140-6736(21)02143-7 **Dickerson, F. et. al. (2018). Adjunctive probiotic microorganisms to prevent rehospitalization in patients with acute mania: A randomized controlled trial. Bipolar Disorders;20(7):614-621. Doi: 10.1111/bdi.12652. Music: Matei Sax. Cubano Loco

In this episode, Hannah discusses the many holistic-y treatments for being sick during the winter, such as plant-remedies and old-school traditions such as Chicken Soup. Acknowledgments to: https://www.webmd.com/women/dry-indoor-air https://realestate.usnews.com/real-estate/slideshows/7-ways-to-cut-the-dry-air-in-your-home-this-winter?slide=9 https://simplyhealth.today/20-classic-home-remedies-for-the-cold/?utm_source=%2Bcold%20%2Bremedies&utm_medium=20ClassicHomeRemediesfortheCold&utm_campaign=adw_us&msclkid=c2454d6cbf8c110c7ea92ca86d80b977#google_vignette --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app

Metabolic resuscitation is an adjunctive therapy for sepsis and septic shock, which consists of a combination of vitamin C, glucocorticoids, and vitamin B1 or their components. Recently, there has been considerable interest in this treatment. However, due to the wide range of combinations of its components, there is no evidence for the effectiveness of this therapy. To fill this gap, a network meta-analysis (NMA) and component NMA was conducted. This analysis summarised the available evidence concerning these therapies and determined any incremental effect of each component when added to sepsis treatment. In the following podcast, Dr Fuji explains the methodology employed and details the study results. Original paper: https://doi.org/10.1007/s00134-021-06558-0 (Effect of adjunctive vitamin C, glucocorticoids, and vitamin B1 on longer-term mortality in adults with sepsis or septic shock: a systematic review and a component network meta-analysis.) Speakers: Tomoko FUJII. Intensive Care Unit, Jikei University Hospital, 3-25-8, Nishi-Shimbashi, Minato-ku, Tokyo, 105-8461 (JP). Australian and New Zealand Intensive Care Research Centre. Inès LAKBAR. Service Anesthésie - Réanimation Pr LEONE - AP-HM - Hôpital Nord - Marseille (FR).

In this episode, Dr. Andrew Cutler interviews Dr. Roger McIntyre on best practices for using adjunctive treatment for major depressive disorder. Optional CME/CE Credits and Certificate Instructions: After listening to the podcast, to take the optional posttest and receive CME/CE credit, click https://nei.global/POD21-MDD Learning Objectives: After completing this educational activity, you should be better able to: Discuss earlier identification of partial response to anti-depressants and advantages to implementing augmentation strategies sooner to improve treatment outcomes Increase awareness about evidence-based adjunctive treatments that are FDA-approved for depression Examine the pharmacological profiles of approved adjunctive atypical antipsychotic treatments in terms of how they relate to therapeutic benefits and adverse reactions Accreditation: In support of improving patient care, Neuroscience Education Institute (NEI) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  NEI designates this online live activity for a maximum of 1.0 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. CME/CE Credit Types. The following are being offered for this activity: Nursing (ANCC): 1.0 contact hour Pharmacy (ACPE): 1.0 application-based contact hour Physician (ACCME): 1.0 AMA PRA Category 1 Credit ™ Physician Assistant (AAPA): 1.0 Category 1 CME credit Psychology (APA): 1.0 CE credit Social Work (ASWB-ACE): 1.0 ACE CE credit Non-Physician Member of the Healthcare Team: Certificate of Participation stating the program is designated for 1.0 AMA PRA Category 1 Credit ™ Peer Review: The content was peer-reviewed by an MD specializing in psychiatry to ensure the scientific accuracy and medical relevance of information presented and its independence from bias. NEI takes responsibility for the content, quality, and scientific integrity of this CME/CE activity. Disclosures: All individuals in a position to influence or control content are required to disclose all relevant financial relationships. Potential conflicts of interest are identified and resolved prior to the activity being presented. Interviewer Andrew J. Cutler, MD Clinical Associate Professor, Department of Psychiatry, SUNY Upstate Medical University, Syracuse, NY Chief Medical Officer, Neuroscience Education Institute, Carlsbad, CA Consultant/Advisor: AbbVie, Acadia, AiCure, Alfasigma, Alkermes, Allergan, Atentiv, Cognitive Research, Intra-Cellular, Ironshore, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Sage, Sunovion, Supernus, Takeda, Teva Speakers Bureau: AbbVie, Acadia, Alkermes, Allergan, Intra-Cellular, Ironshore, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Sunovion, Supernus, Takeda, Teva, Tris  Interviewee Roger S. McIntyre, MD, FRCPC Professor, Departments of Psychiatry and of Pharmacology; Head, Mood Disorders Psychopharmacology Unit, University Health Network; University of Toronto, Toronto, ON, Canada Grant/Research: CIHR/GACD/National Natural Science Foundation of China Consultant/Advisor: AbbVie, Bausch Health, Eisai, Intra-Cellular, Janssen, Kris, Lundbeck, Neurocrine, Novo Nordisk, Otsuka, Pfizer, Purdue, Sunovion, Takeda Speakers Bureau: AbbVie, Bausch Health, Eisai, Intra-Cellular, Janssen, Kris, Lundbeck, Neurocrine, Novo Nordisk, Otsuka, Pfizer, Purdue, Sunovion, Takeda  Pre-Interview Author Sabrina K. Bradbury-Segal, PhD Medical Writer, Neuroscience Education Institute, Carlsbad, CA No financial relationships to disclose. The Planning Committee and Peer Reviewer have no financial relationships to disclose. Disclosure of Off-Label Use: This educational activity may include discussion of unlabeled and/or investigational uses of agents that are not currently labeled for such use by the FDA. Please consult the product prescribing information for full disclosure of labeled uses. Cultural and Linguistic Competency: A variety of resources addressing cultural and linguistic competency can be found here: https://nei.global/culture Support: This activity is supported by an unrestricted educational grant from Otsuka and Lundbeck. Released: October 21, 2021          CE credit expires: October 21, 2024    

In this month's episode of our JVS - VL Editor's Choice series, Jacob, Joshua, and Andrew discuss July's selected articles with Editor-in-Chief of the JVS, Dr. Peter Gloviczki. Dr. Gloviczki YouTube Video Articles Discussed: Risk factors for acute kidney injury after pharmacomechanical thrombolysis for acute deep vein thrombosis (Editor's Choice and CME) Hypersensitivity reaction after cyanoacrylate closure of incompetent saphenous veins in patients with chronic venous disease: A retrospective study The randomized, controlled ATLANTIS trial of aquatic therapy for chronic venous insufficiency Adjunctive techniques to minimize thrombotic complications following microfoam sclerotherapy of saphenous trunks and tributaries    If you enjoy our content, please contribute to Support Audible Bleeding! Help us improve through our ALL NEW Listener Survey! Follow us on Twitter: @AudibleBleeding  

Tony Burris L.Ac has a masters in science in Traditional Chinese Medicine, and he’s a licensed acupuncturist. Some of his patients include members of the San Diego Chargers, Washington Redskins, Denver Broncos, Chicago Bears and Detroit Lions just to name a few! You can find Tony and more information about his acupuncture on his website, https://www.eagleacupuncture.com/    Today, Tony joins us for the fourth episode in his series to discuss some of TCM’s adjunctive therapies for athletes. We delve into Tui Na bodywork, PNF stretching, Qi Gong, and mindfulness and mindset.    Dr. Hammerstedt and her lifestyle coaching team can be found at www.wholisthealth.com and @wholisthealth on Facebook and Instagram as well as the public Facebook group Curate Your Health. Wholist helps high performing women and men lose weight for the last time, with an innovative food and mindset coaching program to blueprint YOUR optimal body and mind, with real food, real work, real results… and no products or BS. Come curate YOUR sustainable health future, and personal and professional dynasty.   And remember, Who you choose to be Matters. You are valuable, You are worth this, You are your WholeYou

Welcome to the first episode of our podcast for current and aspiring intensivists. Our panel of medical professionals and students will examine specific patient cases, symptoms, and treatments. Today's episode focuses on anaphylaxis. Join us! https://www.dropbox.com/s/3mtdeas0hqu6j9j/Anaphylaxis%20Card.jpg?dl=1 (>>Click here to download the PICU card for this episode

Shannon Carlin - Oncology Naturopath joins me to share her Natural Medicine approaches to support patients with Breast Cancer. A bit more about Shannon: Shannon will listen to you, give you hope, and provide you with a research and evidence-based treatment, to facilitate your health. Shannon provides a plan for your health, not just your dis-ease. She is a Naturopath, Nutritionist, and Herbalist who offers: ✓ Adjunctive integrative oncology support ✓ Incorporates research-informed interventions ✓ Extensive knowledge on food and nutrition Shannon has also got many achievements under her belt including: ✓ Symposium presenter: 10th International Conference on Herbal Medicine on Adjunctive Breast Cancer Care ✓ Emerging Naturopath of the Year 2016 You can find more about Shannon below: https://www.thenaturopathicbalance.com.au/ https://www.instagram.com/thenaturopathicbalance/ https://www.facebook.com/shannoncarlinnaturopath04/ Email: shannoncarlin@bigpond.com

How Is Ozone Therapy Being Used To Treat COVID-19 in Europe? | This episode is brought to you by Simple Mills, Paleovalley, and ApeelWhen we read the local headlines and stick to our own quarantine routines, it might be easy to forget that this virus is affecting the entire world. And as scary as that is, it also means we can collaborate with other countries to gain the best possible understanding of how to treat COVID-19. Since the spring, I’ve been reaching out to different doctors across the world to learn about their various COVID protocols. One of the most valuable contacts I’ve had, Dr. Paolo Tordiglione, has been seeing amazing results with ozone therapy and he is my guest on this episode of The Doctor’s Farmacy. Dr. Tordiglione is a Senior Consultant in Neuroanesthesia in the Neuro-ICU at Policlinico Umberto I University of Rome Sapienza, Italy. He is a specialist in pain medicine and an expert in ozone therapy. He is the former President of Doctors of the World Italy, founder of Physicians for Human Rights Italy, Vice President of the Academy of BioRegenerative Medicine, and a member of the Molecular Medicine Academy. He is currently developing a company called PLEYO, with the goal of scientifically improving the quality of human life, and has been researching ozone therapy since 2000.This episode is brought to you by Simple Mills, Paleovalley, and Apeel.Right now, Simple Mills is offering Doctor’s Farmacy listeners 20% off. Just head over to simplemills.com and use code HYMAN20 to try their Artisan Bread Mix and other amazing products to stock up for the holidays. Paleovalley is offering 15% off your entire first order. Just go to paleovalley.com/hyman to check out all their clean Paleo products and take advantage of this deal.Apeel, a family of plant-derived coatings that, when applied to the outside of produce, keeps it fresh two times longer, is doing amazing things to extend the shelf life of fruits and vegetables. To learn more about Apeel, check out their frequently asked questions page at apeel.com/faqs. Here are more of the details from our interview: Where are we now in our understanding of COVID-19 and treatment for it? (7:32)What is ozone therapy and what is its history of use? (13:41)The rationale for using ozone therapy to treat COVID-19 (20:42)Various methods of ozone therapy and how Dr. Tordiglione uses ozone therapy in the treatment of COVID-19 patients (24:15)Dr. Tordiglione’s research using ozone therapy in women undergoing chemotherapy for breast cancer (34:46)Case reports, studies, and clinical trials from around the world looking at ozone therapy in the treatment of COVID-19 (37:39)Preliminary results from Dr. Tordiglione’s study of patient outcomes from ozone therapy in the treatment of COVID-19 (43:40)How the FDA’s ruling on inhaled ozone in the ‘90s has blocked the use of ozone therapy in the United States (52:00)My personal healing experience with ozone therapy (55:20)Adjunctive nutritional and supplemental therapy for COVID-19 (1:00:08) Learn more about Dr. Tordiglione at https://www.paolotordiglione.com/. Find his study, “Ozone as Adjuvant Support in the Treatment of COVID19: A Preliminary Report of Probiozovid Trial” here: https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.26636Additional research:Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora (PROBIOZOVID) https://clinicaltrials.gov/ct2/show/NCT04366089?term=oxygen+ozone&draw=2&rank=2Oxygen-ozone (O2-O3) immunoceutical therapy for patients with COVID-19. Preliminary evidence reportedhttps://www.sciencedirect.com/science/article/pii/S1567576920314946?via%3DihubPotential Role of Oxygen–Ozone Therapy in Treatment of COVID-19 Pneumoniahttps://pubmed.ncbi.nlm.nih.gov/32804917/ See acast.com/privacy for privacy and opt-out information.

Cetamina como adjunto a eletroconvulso terapia: meta analise e revisão sistemática atualizada Este é um podcast para médicos sob responsabilidade do Dr. Tiago Gil, médico anestesista CRMSP 157384 RQE 64871 EXCLUSIVO PARA DIVULGAÇÃO CIENTÍFICA PARA MÉDICOS A medicina é uma ciência que está em evolução e este podcast não deve ser utilizado como guia terapêutico. Esse episódio foi gravado como verdade até agosto de 2020 Meu email é contato@cetamina.com , @cetamina no Instagram e centrodecetamina.com.br Referências Bibliográficas: [1] A. McGirr, M. T. Berlim, D. J. Bond, P. Y. Chan, L. N. Yatham, and R. W. Lam, “Adjunctive ketamine in electroconvulsive therapy: Updated systematic review and meta-analysis,” British Journal of Psychiatry, vol. 210, no. 6. Royal College of Psychiatrists, pp. 403–407, 01-Jun-2017. [2] S. V. Faraone, “Interpreting estimates of treatment effects: Implications for managed care,” P T, vol. 33, no. 12, 2008.

Please Leave a Review! Michelle continues to indulge her love for and fascination with all things perio by interviewing a fellow hygienist who's trained on advanced periodontal tools that Michelle only wishes she could get her hands on.   Amber Auger, RDH, is a speaker, professional coach and clinical trainer based in the Greater Boston Area. Apart from her comprehensive periodontal knowledge, Amber also has extensive experience using and training professionals on laser tools for the purposes of periodontal treatment.   In this episode, Amber discusses the advantages of nuances of using lasers, explains where we can really make a significant change for both patients and professionals, and reveals why she's excited for the next ten years.     EPISODE HIGHLIGHTS:   Interview starts: 7:49   - Amber takes us through her journey as a dental hygienist and discusses her experience with lasers.   - How exactly are lasers used to treat periodontal disease?   - Why you really need to take your time while probing.   - The reason Amber establishes a personal connection with her patients before starting in on the serious questions.   - What patients can do to test themselves for periodontal issues.   - Why Amber and her colleagues implement a probiotic rather than antibiotic protocol for patients after laser treatment.   - The trials and tribulations of convincing patients to use water picks.        QUOTES:   “It has been an absolutely amazing journey to dental hygiene.”   “When I'm chatting with my patient and I'm sitting them down and reviewing their medical history, I take the time to sit and listen.”   “When you're taking the time to empower them and educate them on a higher level, you're gonna have compliance through the roof as well as patients who follow you.”   “We are met with opportunities as we think we are worthy of them.”   “We need to be insurance-aware but not dictated by insurance.”   LINKS:   Amber's homepage: https://www.amberauger.com/   Amber's email: amberaugerrdh@gmail.com    Amber on Facebook: https://www.facebook.com/AmberAugerRDHMPH   Amber on Instagram: https://www.instagram.com/amberaugerrdh/   Amber on Twitter: https://twitter.com/AmberAugerRDH   THIS EPISODE COUNTS FOR CE! - but read the disclaimer below as it might not count for your state. Go here to take the test and get your CE Credit!   A Tale of Two Hygienists homepage - https://ataleoftwohygienists.com/     AToTH on Facebook - https://www.facebook.com/aTaleOfTwoHygienists/     AToTH on Instagram - https://www.instagram.com/ataleoftwohygienists     AToTH on LinkedIn - https://www.linkedin.com/company/atoth/?originalSubdomain=ca  

Please Leave a Review! Michelle continues to indulge her love for and fascination with all things perio by interviewing a fellow hygienist who’s trained on advanced periodontal tools that Michelle only wishes she could get her hands on.   Amber Auger, RDH, is a speaker, professional coach and clinical trainer based in the Greater Boston Area. Apart from her comprehensive periodontal knowledge, Amber also has extensive experience using and training professionals on laser tools for the purposes of periodontal treatment.   In this episode, Amber discusses the advantages of nuances of using lasers, explains where we can really make a significant change for both patients and professionals, and reveals why she’s excited for the next ten years.     EPISODE HIGHLIGHTS:   Interview starts: 7:49   - Amber takes us through her journey as a dental hygienist and discusses her experience with lasers.   - How exactly are lasers used to treat periodontal disease?   - Why you really need to take your time while probing.   - The reason Amber establishes a personal connection with her patients before starting in on the serious questions.   - What patients can do to test themselves for periodontal issues.   - Why Amber and her colleagues implement a probiotic rather than antibiotic protocol for patients after laser treatment.   - The trials and tribulations of convincing patients to use water picks.        QUOTES:   “It has been an absolutely amazing journey to dental hygiene.”   “When I’m chatting with my patient and I’m sitting them down and reviewing their medical history, I take the time to sit and listen.”   “When you’re taking the time to empower them and educate them on a higher level, you’re gonna have compliance through the roof as well as patients who follow you.”   “We are met with opportunities as we think we are worthy of them.”   “We need to be insurance-aware but not dictated by insurance.”   LINKS:   Amber’s homepage: https://www.amberauger.com/   Amber’s email: amberaugerrdh@gmail.com    Amber on Facebook: https://www.facebook.com/AmberAugerRDHMPH   Amber on Instagram: https://www.instagram.com/amberaugerrdh/   Amber on Twitter: https://twitter.com/AmberAugerRDH   THIS EPISODE COUNTS FOR CE! - but read the disclaimer below as it might not count for your state. Go here to take the test and get your CE Credit!   A Tale of Two Hygienists homepage - https://ataleoftwohygienists.com/     AToTH on Facebook - https://www.facebook.com/aTaleOfTwoHygienists/     AToTH on Instagram - https://www.instagram.com/ataleoftwohygienists     AToTH on LinkedIn - https://www.linkedin.com/company/atoth/?originalSubdomain=ca  

John G. Laffey, MD, and Nida Qadir, MD, join CHEST Podcast Moderator, Gretchen Winter, MD, to discuss the frequency and patterns of use of adjunctive strategies in patients with moderate to severe ARDS. DOI: https://doi.org/10.1016/j.chest.2020.01.041  

Fred, Pedro, Rapha e João selecionaram quatro tópicos polêmicos de sepse para discutir nesse episódio! Um tema relevante para todos. Ficou com alguma dúvida, quer mandar alguma sugestão ou crítica? Entra em contato com a gente através do Instagram ou Twitter @tadeclinicagem ou e-mail tadeclinicagem@gmail.com. Assina nossa Newsletter semanal com os temas mais interessantes da clínica médica! O link está disponível no Instagram e no Twitter. MINUTAGEM Em breve REFERÊNCIAS 1. FUJII, Tomoko et al. Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock: the vitamins randomized clinical trial. Jama, v. 323, n. 5, p. 423-431, 2020 2. DE GROOTH, Harm-Jan; ELBERS, Paul WG; VINCENT, Jean-Louis. Vitamin C for Sepsis and Acute Respiratory Failure. Jama, v. 323, n. 8, p. 792-792, 2020 3. TRUWIT, Jonathon D. et al. Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial. Jama, v. 322, n. 13, p. 1261-1270, 2019 4. CHANG, Ping et al. Combined treatment with hydrocortisone, vitamin C, and thiamine for sepsis and septic shock (HYVCTTSSS): A randomized controlled clinical trial. Chest, 2020 5. VENKATESH, Balasubramanian et al. Adjunctive glucocorticoid therapy in patients with septic shock. New England Journal of Medicine, v. 378, n. 9, p. 797-808, 2018. 6. ANNANE, Djillali et al. Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Intensive care medicine, v. 43, n. 12, p. 1751-1763, 2017. 7. ROCHWERG, Bram et al. Corticosteroids in sepsis: an updated systematic review and meta-analysis. Critical care medicine, v. 46, n. 9, p. 1411-1420, 2018 8. ANTAL, Oana, et al. "Initial Fluid Resuscitation Following Adjusted Body Weight Dosing in Sepsis and Septic Shock." The Journal of Critical Care Medicine 5.4 (2019): 130-135 9. SEYMOUR, Christopher W., et al. "Time to treatment and mortality during mandated emergency care for sepsis." New England Journal of Medicine 376.23 (2017): 2235-2244 10. OUELLETTE, Daniel R., and Sadia Z. Shah. "Comparison of outcomes from sepsis between patients with and without pre-existing left ventricular dysfunction: a case-control analysis." Critical Care 18.2 (2014): R79 11. RAJDEV, Kartikeya, et al. "Fluid resuscitation in patients with end-stage renal disease on hemodialysis presenting with severe sepsis or septic shock: A case control study." Journal of critical care 55 (2020): 157-162 12. BHATTACHARJEE, Poushali, Dana P. Edelson, and Matthew M. Churpek. "Identifying patients with sepsis on the hospital wards." Chest 151.4 (2017): 898-907 13. HAYDAR, Samir, et al. "Comparison of QSOFA score and SIRS criteria as screening mechanisms for emergency department sepsis." The American journal of emergency medicine 35.11 (2017): 1730-1733 14. JIANG, Jianjun, et al. "Head-to-head comparison of qSOFA and SIRS criteria in predicting the mortality of infected patients in the emergency department: a meta-analysis." Scandinavian journal of trauma, resuscitation and emergency medicine 26.1 (2018): 56 15. GOULDEN, Robert, et al. "qSOFA, SIRS and NEWS for predicting inhospital mortality and ICU admission in emergency admissions treated as sepsis." Emerg Med J 35.6 (2018): 345-349

A diagnosis of acute myeloid leukemia (AML) was once an emergency, requiring immediate treatment. Today, the need to start treatment is still urgent, but many patients can benefit by waiting a few days for testing to reveal a fuller picture of the disease. That’s the advice of James M. Foran, MD, of the Mayo Clinic. He joins Blood & Cancer host David H. Henry, MD, of the Pennsylvania Hospital, Philadelphia, to walk through some patient scenarios and the newest treatment options. In Clinical Correlation, Ilana Yurkiewicz, MD, of Stanford (Calif.) University, talks about what patients do and do not remember from their visits. Practice points: Rapid testing results can drive important choices in the initial treatment of AML. Adjunctive therapies may improve survival by 7%-20% in appropriate patients. Although a total work-up may take up to 2 weeks, new research suggests it is feasible to get rapid sequencing/cytogenetic testing and assign treatment within 7 days. Treatment varies: Daunorubicin and cytarabine (Vyxeos) are still central treatment strategies, but there may be survival advantages (7%-20% improvement) by adding adjunctive therapies, if indicated. A few are listed below: Liposomal formulations of daunorubicin-cytarabine (CPX351) can have survival advantages in therapy-related AML or AML with myelodysplastic syndrome (MDS)-related changes. Gemtuzumab (Mylotarg) may be indicated for core binding factor (CBF) AML. Midostaurin (Rydapt) may improve survival in patients with FMS-like tyrosine kinase (FLT) 3 Enasidenib (Idhifa) may be indicated in patients with IDH mutations. Options for elderly patients: In a recent study, CC 486 (oral azacitidine) showed a significant survival advantage and remission duration in elderly patients with AML. The drug is not yet available but could eventually be a maintenance therapy option for patients who do not go on to transplant. Azacitidine, plus or minus an IDH2 inhibitor, showed much higher remission rates in elderly patients, but did not translate into a survival advantage. AML in the outpatient setting: Many patients with AML are being increasingly managed as outpatients, which ultimately will require a different kind of support infrastructure in our hospitals and clinics. Show notes by Debika Biswal Shinohara, MD, PhD, resident in the department of internal medicine, University of Pennsylvania, Philadelphia. Dr. Henry and Dr. Yurkiewicz reported having no financial conflicts relevant to this episode. Dr. Foran reported advisory board membership with Pfizer, Jazz Pharma, and Novartis.  * * *  For more MDedge Podcasts, go to mdedge.com/podcasts Email the show: podcasts@mdedge.com Interact with us on Twitter: @MDedgehemonc David Henry on Twitter: @davidhenrymd Ilana Yurkiewicz on Twitter: @ilanayurkiewicz

JAACAP March 2020: Contributing Editor Dr. John Erik Leikauf interviews Dr. Kenneth Towbin on the effects of adding citalopram to methylphenidate in the treatment of chronic severe irritability in youth using a double-blind randomized placebo-controlled design.

JAACAP March 2020: Contributing Editor Dr. John Erik Leikauf interviews Dr. Kenneth Towbin on the effects of adding citalopram to methylphenidate in the treatment of chronic severe irritability in youth using a double-blind randomized placebo-controlled design.

In this podcast, Gregory Krauss, MD, discusses his research on cenobamate as adjunctive therapy for adults with uncontrolled focal seizures, how the results of this research aided in cenobamate's approval by the US Food and Drug Administration, and more. More at: www.consultant360.com/neurology.

Show notes at pharmacyjoe.com/episode457. In this episode, I ll discuss adjunctive cholestyramine therapy for thyroid storm. The post 457: Adjunctive cholestyramine therapy for thyroid storm appeared first on Pharmacy Joe.

Mary T. Bessesen, MD joins JAMA Network editors to discuss a cohort study that compares amputation and mortality rates among patients treated in the Veterans Health Administration for diabetic foot osteomyelitis with and without rifampin. Read the article here: https://ja.ma/37IBIT8. JNO Live is a weekly broadcast featuring conversations about the latest research being published in JAMA Network Open. Follow us on Facebook, Twitter and YouTube for details on the next broadcast.

Should we add azithromycin prophylaxis prior to emergency Caesarean section? Ureaplasma are a common cause for endometritis, is sensitive to azithromycin, but not to cephalosporins. This trial found a significant reduction in infectious morbidity. So is it a no brainer? The boffins duke it out. Tita AT, Szychowski JM, Boggess K, Saade G, Longo S, Clark E, Esplin S, Cleary K, Wapner R, Letson K, Owens M. Adjunctive azithromycin prophylaxis for cesarean delivery. New England Journal of Medicine. 2016 Sep 29;375(13):1231-41.

Go online to PeerView.com/UGR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.In this activity, experts in PKU discuss available adjunctive treatments, which provide an opportunity to lower blood Phe levels while potentially easing dietary restrictions and lessening the burden of this disease. Upon completion of this activity, participants should be better able to: Employ current practice guidelines and standards of care when managing individuals with phenylketonuria (PKU), Identify the challenges associated with dietary therapy in patients with PKU as they transition from childhood to adolescence and into adulthood, Describe the mechanisms of action of available adjunctive treatment approaches for the management of PKU, Assess available data on the efficacy, safety, and tolerability of approved adjunctive pharmacologic therapies for the management of adults with PKU, Apply available adjunctive therapies as part of a personalized approach to the management of adults with PKU.

Go online to PeerView.com/UGR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.In this activity, experts in PKU discuss available adjunctive treatments, which provide an opportunity to lower blood Phe levels while potentially easing dietary restrictions and lessening the burden of this disease. Upon completion of this activity, participants should be better able to: Employ current practice guidelines and standards of care when managing individuals with phenylketonuria (PKU), Identify the challenges associated with dietary therapy in patients with PKU as they transition from childhood to adolescence and into adulthood, Describe the mechanisms of action of available adjunctive treatment approaches for the management of PKU, Assess available data on the efficacy, safety, and tolerability of approved adjunctive pharmacologic therapies for the management of adults with PKU, Apply available adjunctive therapies as part of a personalized approach to the management of adults with PKU.

Go online to PeerView.com/UGR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.In this activity, experts in PKU discuss available adjunctive treatments, which provide an opportunity to lower blood Phe levels while potentially easing dietary restrictions and lessening the burden of this disease. Upon completion of this activity, participants should be better able to: Employ current practice guidelines and standards of care when managing individuals with phenylketonuria (PKU), Identify the challenges associated with dietary therapy in patients with PKU as they transition from childhood to adolescence and into adulthood, Describe the mechanisms of action of available adjunctive treatment approaches for the management of PKU, Assess available data on the efficacy, safety, and tolerability of approved adjunctive pharmacologic therapies for the management of adults with PKU, Apply available adjunctive therapies as part of a personalized approach to the management of adults with PKU.

Go online to PeerView.com/UGR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.In this activity, experts in PKU discuss available adjunctive treatments, which provide an opportunity to lower blood Phe levels while potentially easing dietary restrictions and lessening the burden of this disease. Upon completion of this activity, participants should be better able to: Employ current practice guidelines and standards of care when managing individuals with phenylketonuria (PKU), Identify the challenges associated with dietary therapy in patients with PKU as they transition from childhood to adolescence and into adulthood, Describe the mechanisms of action of available adjunctive treatment approaches for the management of PKU, Assess available data on the efficacy, safety, and tolerability of approved adjunctive pharmacologic therapies for the management of adults with PKU, Apply available adjunctive therapies as part of a personalized approach to the management of adults with PKU.

Go online to PeerView.com/UGR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.In this activity, experts in PKU discuss available adjunctive treatments, which provide an opportunity to lower blood Phe levels while potentially easing dietary restrictions and lessening the burden of this disease. Upon completion of this activity, participants should be better able to: Employ current practice guidelines and standards of care when managing individuals with phenylketonuria (PKU), Identify the challenges associated with dietary therapy in patients with PKU as they transition from childhood to adolescence and into adulthood, Describe the mechanisms of action of available adjunctive treatment approaches for the management of PKU, Assess available data on the efficacy, safety, and tolerability of approved adjunctive pharmacologic therapies for the management of adults with PKU, Apply available adjunctive therapies as part of a personalized approach to the management of adults with PKU.

Go online to PeerView.com/UGR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.In this activity, experts in PKU discuss available adjunctive treatments, which provide an opportunity to lower blood Phe levels while potentially easing dietary restrictions and lessening the burden of this disease. Upon completion of this activity, participants should be better able to: Employ current practice guidelines and standards of care when managing individuals with phenylketonuria (PKU), Identify the challenges associated with dietary therapy in patients with PKU as they transition from childhood to adolescence and into adulthood, Describe the mechanisms of action of available adjunctive treatment approaches for the management of PKU, Assess available data on the efficacy, safety, and tolerability of approved adjunctive pharmacologic therapies for the management of adults with PKU, Apply available adjunctive therapies as part of a personalized approach to the management of adults with PKU.

In this Audio Summary, Erik discusses the evidence around whether intratesticular lidocaine works as a good adjunctive analgesic in cats undergoing orchiectomies. Read the full Knowledge Summary here. Audio Summaries are a free resource that enables vets and vet nurses to access and digest relevant and up-to-date evidence quicker and easier! A time-saving way to make better and faster evidence-based decisions.

We get to really nerd out this week as we invite on Ryan Nolan, DMD. Ryan is a practitioner, commentator, and creator of the amazing podcast The Biofilm Factor — where he discusses biofilm management and diet with other dental professionals. He is also a co-founder of Elementa Silver, which specializes in nano silver-driven oral cleaning solutions. His work in dentistry and oral health care is guided by his previous education in chemical engineering, and he approaches the field with an eye for results-based research.In this episode, Ryan discusses why he switched from chemical engineering to dentistry (and how the former has guided his work), lays out his case for nano silver as a dental cleaning product, and voices his concern at how many trendy dental products are not supported by science. Listen to the end to hear how he really feels about Charcoal, Chx Rinse, Toothpaste companies and more!EPISODE HIGHLIGHTS:The interview begins: 3:11- How Ryan's product design work allows him to express his creativity within dental work.- Pinpointing areas within the dental profession that could still be vastly improved through new technology and treatments.- The "21st century gap" in dental care and treatment and how much catch-up the industry needs to do.- What are "preventative products" and why it's important to make a push for them.- The limitations of in vitro testing and some important factors that process can't account for. -What are the pros and cons of Silver Diamine Fluoride- How silver, much like family trees, has several generations.- Are there benefits to using silver in toothbrush bristles?- Balancing treatment with price to do the absolute best by our patients.- The skeletons in chlorhexidine's closet that make it an inadvisable treatment.- Ryan dishes out the truth about Sensodyne and explains why he's skeptical of certain toothpaste trends.QUOTES:"I could never shake this idea that we couldn't do things better, and that's kind of where I'm at right now.""Dental innovation in prevention sectors is basically nonexistent.""It's like filling a house with balls, right? Eventually, it's gonna be more dense, if that makes sense.""The thing I love about nanosilver is that you don't need to be a genius to hit the broad side of a barn.""The human body has got so many defense systems in place to prevent a lot of these things from developing.""Anytime you put something through a heated process and it's plastic, there's gonna be some no-nos that come out of that.""Ortho patients need interdental brushes, 100%.""You can't deny data."LINKS:The Biofilm Factor - http://thebiofilmfactor.com/Elementa Silver - https://elementasilver.com/ Elementa Silver on Amazon - https://www.amazon.com/s/ref=bl_dp_s_web_0?ie=UTF8&search-alias=aps&field-keywords=Elementa+Silver Elementa Silver on Instagram (@elementaoralcare) - https://www.instagram.com/elementaoralcare/?hl=en Ryan on Instagram (@ryannolandnd) - https://www.instagram.com/ryannolandmd/?hl=enThank you to Paradise Dental Technologies aka PDT for providing sponsorship for this episodes CE credits!THIS EPISODE COUNTS FOR CE! - but read the disclaimer below as it might not count for your state.Go here to take the test and get your CE Credit! https://www.cezoom.com/taketest/?courseid=3085&testid=1283 Approved Pace Program Provider FAGD/MAGD Credit Approval Does Not Imply Acceptance By A State Or Provincial Board of Dentistry Or AGD Endorsement. 1/1/18- 12/31/19 Provider #373236 Be sure to thank the sponsor for CE for this episode by heading over to www.PDTDental.com and picking up a new instrument or telling them thank you in person at one of the conferences!

We get to really nerd out this week as we invite on Ryan Nolan, DMD. Ryan is a practitioner, commentator, and creator of the amazing podcast The Biofilm Factor — where he discusses biofilm management and diet with other dental professionals. He is also a co-founder of Elementa Silver, which specializes in nano silver-driven oral cleaning solutions. His work in dentistry and oral health care is guided by his previous education in chemical engineering, and he approaches the field with an eye for results-based research.In this episode, Ryan discusses why he switched from chemical engineering to dentistry (and how the former has guided his work), lays out his case for nano silver as a dental cleaning product, and voices his concern at how many trendy dental products are not supported by science. Listen to the end to hear how he really feels about Charcoal, Chx Rinse, Toothpaste companies and more!EPISODE HIGHLIGHTS:The interview begins: 3:11- How Ryan's product design work allows him to express his creativity within dental work.- Pinpointing areas within the dental profession that could still be vastly improved through new technology and treatments.- The "21st century gap" in dental care and treatment and how much catch-up the industry needs to do.- What are "preventative products" and why it's important to make a push for them.- The limitations of in vitro testing and some important factors that process can't account for. -What are the pros and cons of Silver Diamine Fluoride- How silver, much like family trees, has several generations.- Are there benefits to using silver in toothbrush bristles?- Balancing treatment with price to do the absolute best by our patients.- The skeletons in chlorhexidine's closet that make it an inadvisable treatment.- Ryan dishes out the truth about Sensodyne and explains why he's skeptical of certain toothpaste trends.QUOTES:"I could never shake this idea that we couldn't do things better, and that's kind of where I'm at right now.""Dental innovation in prevention sectors is basically nonexistent.""It's like filling a house with balls, right? Eventually, it's gonna be more dense, if that makes sense.""The thing I love about nanosilver is that you don't need to be a genius to hit the broad side of a barn.""The human body has got so many defense systems in place to prevent a lot of these things from developing.""Anytime you put something through a heated process and it's plastic, there's gonna be some no-nos that come out of that.""Ortho patients need interdental brushes, 100%.""You can't deny data."LINKS:The Biofilm Factor - http://thebiofilmfactor.com/Elementa Silver - https://elementasilver.com/ Elementa Silver on Amazon - https://www.amazon.com/s/ref=bl_dp_s_web_0?ie=UTF8&search-alias=aps&field-keywords=Elementa+Silver Elementa Silver on Instagram (@elementaoralcare) - https://www.instagram.com/elementaoralcare/?hl=en Ryan on Instagram (@ryannolandnd) - https://www.instagram.com/ryannolandmd/?hl=enThank you to Paradise Dental Technologies aka PDT for providing sponsorship for this episodes CE credits!THIS EPISODE COUNTS FOR CE! - but read the disclaimer below as it might not count for your state.Go here to take the test and get your CE Credit! https://www.cezoom.com/taketest/?courseid=3085&testid=1283 Approved Pace Program Provider FAGD/MAGD Credit Approval Does Not Imply Acceptance By A State Or Provincial Board of Dentistry Or AGD Endorsement. 1/1/18- 12/31/19 Provider #373236 Be sure to thank the sponsor for CE for this episode by heading over to www.PDTDental.com and picking up a new instrument or telling them thank you in person at one of the conferences!

In this Audio Summary Erik discusses whether the use of intratesticular lidocaine works as a good adjunctive analgesic in dogs undergoing orchiectomies. Read the full Knowledge Summary here. Audio Summaries are a free resource that enables vets and vet nurses to access and digest relevant and up-to-date evidence quicker and easier! A time-saving way to make better and faster evidence-based decisions.

Session ‘Update on Adjunctive Sepsis Therapies’ from the 2nd World Sepsis Congress. Featuring Jean-Louis Vincent, Peter Pickkers, Pierre-Francois Laterre, Richard Hotchkiss, Ashish Khanna, and Jean-Marc Cavaillon as chair. More info: www.worldsepsiscongress.org

The aim of this Continuing Education article is to "provide the learner with information about the effects of surgical smoke and airborne bacteria on surgical team members, patients, and OR air quality and about the available air cleaning technologies for reducing OR air contamination." Barnes, Volume 108, Issue 5 [https://aornjournal.onlinelibrary.wiley.com/doi/full/10.1002/aorn.12391]

Show notes at pharmacyjoe.com/episode340. In this episode I ll: 1. Discuss an article about using piperacillin-tazobactam in ESBL infection. 2. Answer the drug information question “Should adjunctive dexamethasone be given to adults with bacterial meningitis if they have already received at least 1 dose of antibiotics?” 3. Share a tip for responding to inpatient medical emergencies. The post 340: Can piperacillin-tazobactam be used in ESBL, adjunctive dexamethasone in bacterial meningitis, and a tip for responding to inpatient medical emergencies appeared first on Pharmacy Joe.

John Troup, PhD, and Christopher Bump, DC, MS, discuss positioning Nutrition as Adjunctive Care in Chiropractic Care.

En el programa de hoy hablamos sobre el Estudio ARREST. Este estudio, realizado en el Reino Unido, evaluo el efecto de agregar rifampicin all tratamiento antibiótico estándar en la terapia de la bacteriemia por Staphylococcus aureus.    Referencias: Guy E Thwaites y colaboradores. Adjunctive rifampicin for  Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial. The Lancet. Diciembre 2017.    La Frase de la Semana: La tomamos de Vaclav Havel, el escritor y disidente checo cuyas acciones y escritos  ayudaron a destruir al regimen comunista de Checoslovaquia a través de las revoluciones que se iniciaron con el derrumbe del Muro de Berlín y terminaron llevando al propio Sr. Havel al poder. Fue definido como un hombre tímido pero persistente, y  cortés pero obstinado. El Sr. Havel pasó cinco años entrando y saliendo de las cárceles comunistas, vivió durante dos décadas bajo estrecha vigilancia de la policía secreta y soportó la represión de sus obras y ensayos. Escribió 19 obras de teatro, y se mantuvo como uno de los escritores no conformistas más seductores de su generación. Nacido el 5 de octubre de 1936  y fallecido el 18 de diciembre de 2011 sirvió como primer presidente de la República Checa desde 1993 hasta 2003. Antes de eso, también se desempeñó como el último presidente de Checoslovaquia desde 1989 hasta su disolución en 1992.   “La esperanza es un estado mental, no del mundo. La esperanza, en este sentido profundo y poderoso, no es lo mismo que la alegría de que las cosas vayan bien, o la voluntad de invertir en empresas que obviamente se dirigen al éxito, sino la capacidad de trabajar para algo porque es bueno”.    

Session on Novel Adjunctive Sepsis Therapies in Clinical Trials from the 1st World Sepsis Congress. Featuring Kevin Tracey, Jean-Louis Vincent, Peter Pickkers, James Russell, Richard Hotchkiss, Niels Riedemann, Pierre-Francois Latterre, Steven Opal as chair, and Marvin Zick as your host.

Play Episode 5 Here SE could be called a lot of things but one of them should be an "amalgamated practice." There are so many creative threads running through the corpus of the SE tradition that we're indebted to other modalities as much as our own. And we can also learn from them in helpful ways to increase our artfulness within our chosen area of focus as SE Practitioners. Here's a review of some of the adjunctive studies that I found particularly helpful (there are far more besides).

A discussion with Dr. Jason Smith on the utilization of direct peritoneal resuscitation in the treatment of abdominal catastrophes.

Joshua Roffman, MD - Unmet Needs Virtual Grand Rounds - Please visit mghcme.org/unmetneeds for additional information about accreditation.

Interview with John H. Krystal, MD, author of Adjunctive Risperidone Treatment for Antidepressant-Resistant Symptoms of Chronic Military Service-Related PTSD

Jerry J. Zimmerman, MD, PhD, FCCM, discusses his article published in the January Pediatric Critical Care Medicine

Background: Hearing loss is a frequent long-term complication of pneumococcal meningitis (PM). Its main pathological correlate is damage to the organ of Corti and loss of spiral ganglion neurons. The only current treatment option is cochlear implants which require surviving neurons. Here, we investigated the impact of systemically applied neurotrophin-3 (NT-3) on long-term hearing loss and the survival of neurons. Methods: Eighteen hours after infection with S. pneumoniae, C57BL/6 mice were treated with a combination of ceftriaxone with NT-3 or dexamethasone or placebo. Hearing, cochlear damage, and brain damage were assessed by audiometry and histology. Results: The main findings from immunohistochemical visualization of neurotrophins (NT-3, BDNF) and their receptors (TrkB, TrkC, and p75) in the cochlea were (i) enhanced staining for the cell survival-promoting receptor TrkB and (ii) increased NT-3 staining in NT-3 treated mice, showing that systemically applied NT-3 reaches the cochlea. The major effects of adjunctive NT-3 treatment were (i) a reduction of meningitis-induced hearing impairment and (ii) a reduction of spiral ganglion neuronal loss. The efficacy of NT-3 therapy was comparable to that of dexamethasone. Conclusion: Systemically applied NT-3 might be an interesting candidate to improve hearing outcome after pneumococcal meningitis.

Kim Hahn talks with Dr. Alexander Dlugi and Dr. James Golding. Drs. Dlugi and Golding will talk about what role acupuncture and other complementary medicine can play in treating infertility and dealing with its stress.